Interpace Diagnostics Group Inc (NASDAQ:IDXG)

0.892
Delayed Data
As of 4:00pm ET
 -0.013 / -1.44%
Today’s Change
0.72
Today|||52-Week Range
3.20
-12.55%
Year-to-Date
No recent news for Interpace Diagnostics Group Inc.

Today’s Trading

Previous close0.91
Today’s open0.91
Day’s range0.89 - 0.91
Volume91,557
Average volume (3 months)545,487
Market cap$29.0M
Data as of 4:00pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)+75.05%
Earnings growth (this year)+89.63%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+38.73%
P/E ratioNM
Price/Sales0.61
Price/Book0.36

Competitors

 Today’s
change
Today’s
% change
BMRABiomerica Inc+0.01+0.28%
TRILTrillium Therapeutic...+0.15+2.34%
APHBAmpliPhi Biosciences...-0.01-0.91%
GALTGalectin Therapeutic...+0.15+4.40%
Data as of 4:10pm ET, 04/26/2018

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$13.1M
Annual profit (last year)-$9.7M
Net profit margin-64.27%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Jack E. Stover
Senior Vice President-
Operations
Glenn Gershon
Corporate headquarters
Parsippany, New Jersey

Forecasts